Hacker News Reader

Comment by 1996 | Hacker News Reader

1996

When/how will this be exploited by the "designer drugs"/"research chemicals" community to start a drop-shipping psychoactives business?

View on HN

As a company we certainly work hard to ensure our technology is used for approved drug development. We have internal alerts as a company as to the risk of compounds being entered into our system and certainly suppliers and chemical manufacturers have high regulatory oversight. But yes there is always such an unfortunate risk but something we do spend time thinking about.

Maybe I should have phrased my question differently - your startup being exploited by a large group of people with disposable cash and unmet demands is one of the best possible outcomes.

What is an "approved" drug development? Who gets to decide, when the substances are not restricted or scheduled? This means making them is not illegal. So I fail to see how it is an "unfortunate risk", except a risk of making money- which would be fortunate :)

You are missing opportunities just due to your specific moral stance. Drop-shipping is an excellent way to have new customer acquisition pipelines without having to pay for them.

This could be my misunderstanding of the definition of "designer drugs" but I interpreted this as substances which mimic controlled substances but don't trigger drug classification or testing. Assuming this definition then this is something we wouldn't feel comfortable supporting regardless of the cash or demand. My understanding is that these substances are not tested in animal and human trials or approved by governing bodies like the FDA which are critical for the safety and efficacy of use.

Though please do correct me if I'm missing the use case you are referring to.

No correction needed, it is mostly correct - however, a lot of these substances have been tested and do not even mimic controlled substances: MK667 is a good example.

I think you may be throwing the baby with the bathwater, as designing and improving designer drugs is an untapped market with far more potential upsides than downsides.

Reply on news.ycombinator.com